Colliers Securities Upgrades Chembio Diagnostics (CEMI) to Buy

November 6, 2020 8:16 AM EST
Get Alerts CEMI Hot Sheet
Price: $0.46 --0%

Rating Summary:
    1 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Colliers Securities analyst Kyle Bauser upgraded Chembio Diagnostics (NASDAQ: CEMI) from Hold to Buy.


For an analyst ratings summary and ratings history on Chembio Diagnostics click here. For more ratings news on Chembio Diagnostics click here.


Shares of Chembio Diagnostics closed at $4.55 yesterday.


You May Also Be Interested In





Related Categories

Upgrades